Recalls / Class II

Class IID-783-2013

Product

Stanozolol (50 mg/ml and 100 mg/ml) Injection, compounded by Olympia Pharmacy, Orlando, FL

Affected lot / code info

50mg/ml = Lots B5727 Exp 8/27/13, and C5708 Exp 9/8/13 // 100,g/ml =Lot C5706 Exp 9/6/13

Why it was recalled

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Recalling firm

Firm

Lowlite Investments, Inc. D/B/A Olympia Pharmacy

Notification channel

Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit

Type

Voluntary: Firm initiated

Address

6700 Conroy Windermere Rd, Suite 140, Orlando, Florida 32835-3500

Distribution

Quantity

3

Distribution pattern

Nationwide and PR

Timeline

Recall initiated

2013-05-29

FDA classified

2013-07-11

Posted by FDA

2013-07-17

Status

Ongoing

Source: openFDA Drug Enforcement endpoint. Recall record D-783-2013. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.